Ying Lu

5PUBLICATIONS
20CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Apr 29, 2026
OTUD6B-mediated K48 deubiquitination of FXR1 forms a positive feedback loop activating MEK2/ERK signaling in colorectal cancer liver metastasis.

|Jan 12, 2026
Cancer-derived inflammation is associated with bevacizumab resistance and inferior clinical outcomes in patients with metastatic colorectal cancer.

Ya-Nan Li, Yang Wu, Feng-Wen Deng

|Apr 24, 2025
The deubiquitinase YOD1 suppresses tumor progression by stabilizing ZNF24 in clear cell renal carcinoma.

Ji Liu, Ying Lu, Runye Zhu

|Nov 24, 2022
PSMA1 mediates tumor progression and poor prognosis of gastric carcinoma by deubiquitinating and stabilizing TAZ.

Qinyu Yang, Ying Lu, Jianfang Shangguan

|Dec 30, 2020
The Degree of Helicobacter pylori Infection Affects the State of Macrophage Polarization through Crosstalk between ROS and HIF-1α.

Ying Lu, Jianfang Rong, Yongkang Lai

Pageof 1

Frequent Collaborators

2 joint publications

Xu Shu

2 joint publications

Ji Liu

2 joint publications

Hou-Qun Ying

1 joint publications

Jianfang Rong